KLRK1 and neoplasm: Shed NKG2D ligands have been shown to impair NK and T cell function in vitro (9, 31) and to mediate tumor evasion in animal models (32, 33), although in some settings soluble NKG2D ligands may paradoxically mediate tumor rejection (13).